Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Rituximab Exhibits a Long Half-Life Based on a Population Pharmacokinetic Analysis in Non-Hodgkin’s Lymphoma (NHL) Patients.
PaperCitations, authors & open-access status
Rituximab Exhibits a Long Half-Life Based on a Population Pharmacokinetic Analysis in Non-Hodgkin’s Lymphoma (NHL) Patients. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 30 citations, 2007 year and closed oa status.
30
Citations
2007
Year
closed
OA Status